Available from: Kelly AS, Auerbach P, Barrientos-Perez M, Gies I, Hale PM, Marcus C, et al
The guide to GLP-1 before and after results covers the broader class perspective
Wegovy is a brand name for semaglutide , a glucagon-like peptide-1 (GLP-1) receptor agonist licensed in the UK for chronic weight management in adults with a body mass index (BMI) of 30 kg/m or greater, or 27 kg/m or greater in the presence of at least one weight-related comorbidity such as type 2 diabetes or hypertension
But Semaglutide isn't just for weight loss
Providers can sign up for early access here: To view or add a comment, sign in Having spent years owning and operating a pharmacy, I know firsthand what it means when patients have no trustworthy, regulated option for the therapy they need